Notice of Intent to Award Multiple Blanket Purchase Agreements for Sterilely Compounded Pharmaceuticals via 503B Compounding Pharmacies for Gallup Indian Medical Center
Health and Human Services, Department of · INDIAN HEALTH SERVICE
This notice is not accepting responses (deadline was Feb 18, 2026, 12:00 PM EST).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Feb 18, 2026, 12:00 PM EST
- Posted
- Feb 3, 2026
- Solicitation
- NOI-GSUT2-20260003
- Set-aside
- None listed
- Place of performance
- Gallup, NM, USA
- Contracting office
- NAVAJO AREA INDIAN HEALTH SVC · WINDOW ROCK · AZ
- Source
- SAM.gov · updated Jul 5, 2026
Description
Notice of Intent to Award � Multiple Blanket Purchase Agreements The Navajo Area Indian Health Service, Gallup Service Unit in Gallup, NM, intends to place multiple-award Blanket Purchase Agreements (BPA) with Fagron Compounding Services LLC (UEI: F7QNV46N18Q4) and American National Services LLC (UEI: LDNAY53JNV24) for sterilely compounded pharmaceuticals from an FDA-designated 503B facility on an as-needed basis. Items include Phenylephrine 100mcg.ml, Succinylcholine 20mg/10ml, LET 5ml syringe, Oxytoxin 30 units in 500ml (sterile to sterile and API), Epinephrine 8mg per 250ml bag (or other strength/volumes of the same medications in IV bags as available and required on an as-needed basis). Products must be sterilely compounded in an FDA approved facility with a beyond use date of at least 30 days from manufacture. The anticipated period of performance is a base period of one year from the date of award with one option period. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325412- Pharmaceutical Preparation Manufacturing with a small business size standard of 1,300 employees. No further awards will be made unless the need for Gallup Indian Medical Center changes. The prospective, multiple-award BPAs as identified in this notice are sufficient at this time. In accordance with Part 12.201-1(e)(3)(i)(A), establishment of multiple BPAs constitute maximum practicable competition. Any other sources that believe they are capable of fulfilling the government requirements as described are encouraged to submit their capability statement, price lists, and catalogs to the point of contact listed below via email only and no later than 10:00AM (MST) on 2/18/2026. In the event additional BPAs are deemed to be in the best interest of the government, capable vendors may be contacted and be requested to establish a BPA with the Government. This notice of intent is not a request for quotations and a solicitation will not be issued.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$36,321
Middle of the pack for similar past awards
Most similar awards fall between $8,499 and $203,138
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MCKESSON CORPORATION2023 awards$11.98B
- 2BAVARIAN NORDIC A/S1 award$1.17B
- 3EMERGENT BIOSOLUTIONS CANADA INC2 awards$624.99M
- 4CHARTWELL RX LLC3 awards$254.44M
- 5ALVOGEN, INC.1 award$227.68M
- 6MERCK SHARP & DOHME LLC31 awards$157.47M
- 7GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$130.32M
- 8ELUSYS THERAPEUTICS INC1 award$124.52M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID cca2c3fdf91948f79dcab469eae2d406.